Fig. 5.
Fas expression is increased in CD4XL-PBMC in the Bcl-2dim population. PBMC were treated with medium, Leu3a/GAM, or PHA for 3 days and intracytoplasmic Bcl-2 staining was performed in combination with surface Fas antigen and CD3 staining. Fas expression was evaluated separately in Bcl-2dim and Bcl-2high cells gated on the CD3+ cell population.